Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. HYDROCORTANCYL (prednisolone (acétate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

HYDROCORTANCYL (prednisolone (acétate de))

Medicine - Posted on Apr 12 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • prednisolone (acétate de)
history (4)
  • 11/9/17

    HYDROCORTANCYL (prednisolone), glucocorticoid

    Low actual benefit and no clinical benefit demonstrated in the treatment of radiculalgia by epidural injection. HYDROCORTANC...
    CAV :
    54321
    icône flèche
  • 9/17/14

    HYDROCORTANCYL

    -
    icône flèche
  • 11/20/13

    HYDROCORTANCYL (prednisolone (acétate de))

    HYDROCORTANCYL (prednisolone (acétate de))
    icône flèche
  • 11/26/08

    HYDROCORTANCYL (prednisolone (acétate de))

    HYDROCORTANCYL (prednisolone (acétate de))
    icône flèche
Technical information
ATC code
  • H02AB06
Manufacturer
SANOFI-AVENTIS FRANCE
Presentation

HYDROCORTANCYL 5 mg, comprimé 

HYDROCORTANCYL 2,5 POUR CENT, suspension injectable (code CIS : 66330098) 1 flacon(s) en verre de 5 ml - Code CIP : 3400930515587

All our publications
    Drug therapy Eye diseases Joint and rheumatic diseases Nervous system cancers Nose and sinus diseases Pain - Inflammation Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
XaSTqp5KMv2hDX3Y